Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy
Clinical trial NCT03982277 · COMPLETED
Trial details
- NCT number
- NCT03982277
- Sponsor
- Makerere University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2021-03-16
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.